Ocular Therapeutix (OCUL) Convertible Debt (2019 - 2023)
Ocular Therapeutix's Convertible Debt came in at $9.14 million for Q4 2023, down 68.2% from $28.75 million a year earlier but up 4.3% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Convertible Debt (2019 - 2023) Analysis & Trends
Going back to Q1 2019, Ocular Therapeutix's Convertible Debt data covers 20 quarters.
- Convertible Debt carries a four-year compound annual growth rate of -21.7% (FY2019 to FY2023).
- Going back by year, Convertible Debt was $28.75 million in FY2022 (+8.8%), $26.44 million in FY2021 (+8.8%), $24.31 million in FY2020 (unchanged) and $24.31 million in FY2019.
- The five-year range for quarterly Convertible Debt is $8.77 million (Q3 2023) to $29.98 million (Q2 2023).
- Year-over-year, Convertible Debt increased in six of the last eight quarters, with an average decline of 10.6%.
- The fastest year-over-year change in Convertible Debt over five years came in Q2 2020 (growth of 10.3%), and the weakest in Q3 2023 (a decline of 68.9%).
- Business Quant data shows OCUL's Convertible Debt at $8.77 million (Q3 2023), $29.98 million (Q2 2023) and $29.36 million (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 9.14 Mn |
| Sep 30, 2023 | 8.77 Mn |
| Jun 30, 2023 | 29.98 Mn |
| Mar 31, 2023 | 29.36 Mn |
| Dec 31, 2022 | 28.75 Mn |
| Sep 30, 2022 | 28.15 Mn |
| Jun 30, 2022 | 27.57 Mn |
| Mar 31, 2022 | 27.00 Mn |
| Dec 31, 2021 | 26.44 Mn |
| Sep 30, 2021 | 25.89 Mn |
| Jun 30, 2021 | 25.35 Mn |
| Mar 31, 2021 | 24.82 Mn |
| Dec 31, 2020 | 24.31 Mn |
| Sep 30, 2020 | 23.80 Mn |
| Jun 30, 2020 | 26.35 Mn |
| Mar 31, 2020 | 25.30 Mn |
| Dec 31, 2019 | 24.31 Mn |
| Sep 30, 2019 | 23.15 Mn |
| Jun 30, 2019 | 23.90 Mn |
| Mar 31, 2019 | 23.01 Mn |
API Access
Ocular Therapeutix Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();